| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| DC397081 | testis | .a | 1 to 440 | 1 to 440 | tiling clone, | 440/440 (100 %) | 1 diff (99.8 %id) | ||
| BI460360 | testis | .a | 70 to 854 | 1 to 775 | 778/775 (100 %) | 29 diff (96.3 %id) | |||
| BP201211 | amygdala | .a | 71 to 652 | 1 to 581 | 581/581 (100 %) | 10 diff (98.3 %id) | |||
| DC306848 | cerebellum | .a | 75 to 530 | 1 to 457 | 457/457 (100 %) | 1 diff (99.8 %id) | |||
| DN993998 | brain, whole brain | .a | 82 to 630 | 1 to 549 | 549/549 (100 %) | 7 diff (98.8 %id) | |||
| BI559817 | testis | .a | 93 to 832 | 1 to 740 | 740/741 (99 %) | 7 diff (99.1 %id) | |||
| CX752473 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 93 to 784 | 1 to 690 | Submitted on the opposite strand | 690/762 (90 %) | 6 diff (99.3 %id) | ||
| BG717444 | testis | .a | 98 to 870 | 1 to 770 | 770/770 (100 %) | 10 diff (98.8 %id) | |||
| TI_44348077 | .a | 98 to 832 | 129 to 863 | 735/864 (85 %) | 9 diff (99.0 %id) | ||||
| NM_016299.2 | .a | 173 to 1982 | 1 to 1810 | exact | RefSeq, | 1810/1810 (100 %) | 4 diff (99.8 %id) | ||
| DB727742 | testis | .a | 177 to 879 | 1 to 700 | 700/719 (97 %) | 10 diff (98.7 %id) | |||
| CX868507 | embryonic stem | .a | 188 to 651 | 1 to 464 | 464/464 (100 %) | 4 diff (99.2 %id) | |||
| BE613971 | leiomyosarcoma, uterus | .a | 194 to 294 | 1 to 99 | 99/99 (100 %) | 2 diff (98.0 %id) | |||
| BI090080 | cervix | .a | 195 to 314 | 1 to 119 | 119/119 (100 %) | 1 diff (99.2 %id) | |||
| BU589277 | mixed (pool of 40 RNAs) | .a | 202 to 451 | 1 to 250 | 250/1059 (23 %) | 0 diff (100 %id) | |||
| DW410528 | Liver | .a | 210 to 534 | 9 to 333 | 325/333 (97 %) | 9 diff (97.3 %id) | |||
| BP195858 | brain | .a | 214 to 796 | 1 to 582 | 582/582 (100 %) | 4 diff (99.4 %id) | |||
| BP327498 | prostata | .a | 214 to 795 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
| DC362653 | Liver | .a | 215 to 770 | 1 to 556 | 556/556 (100 %) | 3 diff (99.5 %id) | |||
| CX786946 | human embryonic stem cells | .a | 216 to 959 | 1 to 744 | 744/744 (100 %) | 0 diff (100 %id) | |||
| BG739938 | skin | .a | 218 to 996 | 1 to 778 | 778/778 (100 %) | 12 diff (98.5 %id) | |||
| DC361073 | .a | 219 to 794 | 1 to 576 | 576/576 (100 %) | 0 diff (100 %id) | ||||
| BM835015 | stomach | .a | 219 to 652 | 1 to 434 | 434/434 (100 %) | 0 diff (100 %id) | |||
| BP369978 | testis | .a | 219 to 585 | 1 to 367 | 367/560 (65 %) | 4 diff (99.3 %id) | |||
| BG722404 | testis | .a | 222 to 914 | 1 to 694 | 694/694 (100 %) | 11 diff (98.5 %id) | |||
| BI552029 | brain, hippocampus | .a | 222 to 1075 | 1 to 856 | 856/856 (100 %) | 23 diff (97.4 %id) | |||
| DC314568 | amygdala | .a | 225 to 812 | 1 to 588 | 588/588 (100 %) | 1 diff (99.9 %id) | |||
| AK225265 | dermoid cancer | .a | 227 to 1914 | 1 to 1688 | exact | 1688/1688 (100 %) | 0 diff (100 %id) | ||
| AK225651 | stomach mucosa | .a | 227 to 1976 | 1 to 1750 | K68M G253R | AAA | 1750/1750 (100 %) | 2 diff (99.9 %id) | |
| DC327579 | caudate nucleus | .a | 227 to 795 | 1 to 569 | 569/569 (100 %) | 1 diff (99.9 %id) | |||
| DC338497 | subthalamic nucleus | .a | 227 to 766 | 1 to 540 | 540/540 (100 %) | 2 diff (99.7 %id) | |||
| CD387765 | embryonic trophoblasts, made from WA01 stemcells | .a | 227 to 1047 | 23 to 843 | 821/873 (94 %) | 10 diff (98.9 %id) | |||
| BP227556 | .a | 227 to 807 | 1 to 581 | 581/581 (100 %) | 1 diff (99.9 %id) | ||||
| DC360448 | .a | 227 to 693 | 1 to 467 | 467/467 (100 %) | 2 diff (99.6 %id) | ||||
| DC360804 | .a | 227 to 820 | 1 to 594 | 594/594 (100 %) | 0 diff (100 %id) | ||||
| TI_44171833 | .a | 227 to 1045 | 82 to 905 | 824/932 (88 %) | 20 diff (97.9 %id) | ||||
| DC365052 | esophagus | .a | 227 to 769 | 1 to 545 | 545/545 (100 %) | 2 diff (99.7 %id) | |||
| DC365998 | .a | 227 to 741 | 1 to 515 | 515/515 (100 %) | 0 diff (100 %id) | ||||
| BP326954 | prostata | .a | 227 to 807 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
| DC385795 | skeletal muscle | .a | 227 to 793 | 1 to 568 | 568/568 (100 %) | 1 diff (99.9 %id) | |||
| BP340819 | stomach mucosa | .a | 227 to 804 | 1 to 578 | 578/578 (100 %) | 1 diff (99.9 %id) | |||
| DC396291 | testis | .a | 227 to 790 | 1 to 564 | 564/564 (100 %) | 0 diff (100 %id) | |||
| DC400408 | testis | .a | 227 to 756 | 1 to 530 | 530/530 (100 %) | 0 diff (100 %id) | |||
| DC404645 | thymus | .a | 227 to 786 | 1 to 561 | 561/561 (100 %) | 1 diff (99.9 %id) | |||
| TI_57175781 | .a | 228 to 986 | 57 to 818 | 762/819 (93 %) | 16 diff (98.1 %id) | ||||
| DC311879 | alzheimer cortex | .a | 229 to 775 | 1 to 548 | 548/548 (100 %) | 2 diff (99.7 %id) | |||
| DC338066 | subthalamic nucleus | .a | 229 to 794 | 1 to 566 | 566/566 (100 %) | 0 diff (100 %id) | |||
| DB474356 | hippocampus | .a | 229 to 714 | 1 to 486 | 486/486 (100 %) | 0 diff (100 %id) | |||
| DB480226 | hippocampus | .a | 229 to 724 | 1 to 496 | 496/496 (100 %) | 0 diff (100 %id) | |||
| DC360171 | .a | 229 to 743 | 1 to 515 | 515/515 (100 %) | 2 diff (99.7 %id) | ||||
| BP354680 | .a | 229 to 582 | 1 to 357 | 357/416 (85 %) | 3 diff (99.3 %id) | ||||
| DC399446 | testis | .a | 230 to 715 | 1 to 487 | 487/487 (100 %) | 1 diff (99.8 %id) | |||
| DB156845 | thymus | .a | 230 to 525 | 2 to 297 | capped | 296/296 (100 %) | 0 diff (100 %id) | ||
| BI832386 | brain, medulla | .a | 233 to 881 | 19 to 675 | 657/892 (73 %) | 25 diff (97.2 %id) | |||
| TI_57171219 | .a | 233 to 881 | 19 to 675 | 657/892 (73 %) | 25 diff (97.2 %id) | ||||
| CN308284 | embryonic stem cells, DMSO-treated H9 cellline | .a | 234 to 884 | 1 to 651 | 651/651 (100 %) | 1 diff (99.9 %id) | |||
| BI829050 | brain, medulla | .a | 234 to 986 | 1 to 756 | 756/757 (99 %) | 10 diff (98.7 %id) | |||
| BI089822 | cervix | .a | 235 to 314 | 1 to 79 | 79/79 (100 %) | 1 diff (98.8 %id) | |||
| TI_45379662 | .a | 235 to 986 | 53 to 804 | 752/804 (93 %) | 9 diff (98.9 %id) | ||||
| BG258554 | embryonal carcinoma, cell line, testis | .a | 237 to 314 | 1 to 78 | 78/78 (100 %) | 2 diff (97.5 %id) | |||
| BI488839 | brain | .a | 237 to 986 | 1 to 751 | 751/751 (100 %) | 6 diff (99.3 %id) | |||
| CR994829 | T-Lymphocytes | .a | 239 to 1047 | 1 to 809 | 809/852 (94 %) | 0 diff (100 %id) | |||
| DW465344 | Liver | .a | 241 to 590 | 10 to 358 | 349/358 (97 %) | 6 diff (98.4 %id) | |||
| BU950091 | Pancreas, Purified pancreatic islet | .a | 242 to 763 | 1 to 521 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 521/528 (98 %) | 4 diff (99.3 %id) | |
| DC313417 | amygdala | .a | 245 to 797 | 1 to 557 | 557/557 (100 %) | 4 diff (99.3 %id) | |||
| CN308285 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 245 to 993 | 12 to 760 | 749/760 (98 %) | 7 diff (99.1 %id) | |||
| BU949934 | Pancreas, Purified pancreatic islet | .a | 245 to 884 | 12 to 651 | 640/662 (96 %) | 18 diff (97.3 %id) | |||
| BU602060 | mixed (pool of 40 RNAs) | .a | 247 to 1047 | 1 to 800 | 800/823 (97 %) | 11 diff (98.7 %id) | |||
| AA455706 | germinal center B cell | .a | 248 to 770 | 1 to 521 | 521/529 (98 %) | 7 diff (98.7 %id) | |||
| AA294893 | Pancreas | .a | 251 to 625 | 1 to 376 | 376/379 (99 %) | 5 diff (98.7 %id) | |||
| CR610820 | HeLa cells Cot 25-normalized | .a | 251 to 1958 | 1 to 1708 | exact | tiling clone, | 1708/1708 (100 %) | 0 diff (100 %id) | |
| BX341866 | .a | 251 to 1078 | 1 to 830 | fully sequenced, | 830/830 (100 %) | 1 diff (99.9 %id) | |||
| AF112210 | adrenal gland | .a | 252 to 1976 | 1 to 1725 | L282P I312L | AAA | 1725/1725 (100 %) | 4 diff (99.8 %id) | |
| BC119690 | PCR rescued clones | .a | 252 to 1906 | 1 to 1655 | exact | 1655/1655 (100 %) | 0 diff (100 %id) | ||
| BC119691 | PCR rescued clones | .a | 252 to 1906 | 1 to 1654 | N95M K97N L98Y R99D Y100M ... | 1654/1654 (100 %) | 1 diff (100.0 %id) | ||
| AA315407 | colon | .a | 253 to 634 | 1 to 382 | 382/382 (100 %) | 4 diff (99.0 %id) | |||
| DW416351 | Liver | .a | 256 to 549 | 16 to 309 | 294/309 (95 %) | 7 diff (97.8 %id) | |||
| CN308283 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 260 to 885 | 1 to 627 | 627/638 (98 %) | 1 diff (99.9 %id) | |||
| AF143723 | .a | 261 to 1941 | 1 to 1681 | V15E | AAA | 1681/1681 (100 %) | 6 diff (99.7 %id) | ||
| BJ990605 | hepatoblastoma | .a | 262 to 787 | 1 to 526 | 526/526 (100 %) | 0 diff (100 %id) | |||
| AK292323 | testis | .a | 263 to 1976 | 1 to 1714 | V6A D350G | 1714/1714 (100 %) | 2 diff (99.9 %id) | ||
| BP308361 | brain | .a | 263 to 849 | 1 to 587 | 587/587 (100 %) | 0 diff (100 %id) | |||
| BP309625 | brain | .a | 263 to 845 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
| BP222373 | .a | 264 to 845 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | ||||
| DA560548 | heart | .a | 264 to 810 | 2 to 548 | capped | 547/547 (100 %) | 2 diff (99.7 %id) | ||
| DB038643 | testis | .a | 264 to 844 | 2 to 582 | capped | 581/581 (100 %) | 1 diff (99.9 %id) | ||
| AA356570 | .a | 266 to 553 | 1 to 288 | 288/288 (100 %) | 2 diff (99.4 %id) | ||||
| BE881890 | leiomyosarcoma, uterus | .a | 266 to 1022 | 1 to 771 | 740/788 (93 %) | 62 diff (92.2 %id) | |||
| AW962838 | .a | 267 to 688 | 1 to 423 | 423/444 (95 %) | 10 diff (97.8 %id) | ||||
| BU428886 | lymph | .a | 267 to 461 | 1 to 195 | 195/195 (100 %) | 9 diff (95.4 %id) | |||
| CR590065 | Neuroblastoma Cot 25-normalized | .a | 268 to 1958 | 1 to 1691 | exact | 1691/1691 (100 %) | 0 diff (100 %id) | ||
| AL524604 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 268 to 1140 | 1 to 874 | fully sequenced, | 874/874 (100 %) | 1 diff (99.9 %id) | ||
| BI560184 | testis | .a | 280 to 1032 | 1 to 766 | 766/922 (83 %) | 25 diff (97.3 %id) | |||
| TI_44348511 | .a | 285 to 1032 | 130 to 890 | 761/1046 (72 %) | 27 diff (97.5 %id) | ||||
| DA608264 | .a | 286 to 833 | 2 to 550 | capped | 549/549 (100 %) | 6 diff (99.0 %id) | |||
| CD703839 | normal nasopharynx | .a | 306 to 855 | 23 to 572 | 550/572 (96 %) | 7 diff (98.8 %id) | |||
| BQ230338 | melanotic melanoma, skin | .a | 306 to 844 | 1 to 543 | 543/870 (62 %) | 8 diff (99.1 %id) | |||
| BM685771 | eye, Retina Foveal and Macular | .a | 383 to 836 | 8 to 459 | 452/459 (98 %) | 3 diff (99.4 %id) | |||
| TI_57189232 | .a | 467 to 1208 | 77 to 823 | 747/793 (94 %) | 18 diff (97.8 %id) | ||||
| BI861315 | breast, mammary adenocarcinoma, cell line | .a | 468 to 1208 | 1 to 746 | 746/792 (94 %) | 18 diff (97.8 %id) | |||
| ES309590 | occipital hair of pubic hypotrichosispatient, skin | .a | 477 to 883 | 8 to 412 | 405/494 (81 %) | 5 diff (99.0 %id) | |||
| BI091174 | cervix | .a | 486 to 1180 | 1 to 701 | 701/771 (90 %) | 19 diff (97.6 %id) | |||
| DR423299 | eye, Pterygium | .a | 503 to 1123 | 1 to 621 | 621/621 (100 %) | 1 diff (99.9 %id) | |||
| DA731843 | .a | 513 to 1258 | 2 to 753 | capped | 749/767 (97 %) | 12 diff (98.5 %id) | |||
| BI260382 | cervical carcinoma cell line, cervix | .a | 527 to 1242 | 1 to 717 | 717/717 (100 %) | 2 diff (99.8 %id) | |||
| BF035158 | adenocarcinoma, ovary | .a | 700 to 1316 | 1 to 618 | 618/619 (99 %) | 8 diff (98.8 %id) | |||
| BQ951713 | epidermoid carcinoma, cell line, lung | .a | 714 to 1525 | 1 to 818 | 818/927 (88 %) | 10 diff (99.0 %id) | |||
| BI088775 | cervix | .a | 854 to 1653 | 1 to 800 | 798/964 (82 %) | 17 diff (98.3 %id) | |||
| FN110034 | breast carcinoma | .a | 883 to 988 | 108 to 1 | Submitted on the opposite strand | 108/113 (95 %) | 3 diff (97.4 %id) | ||
| EH320848 | .a | 934 to 984 | 1 to 50 | 50/50 (100 %) | 1 diff (98.0 %id) | ||||
| CN308287 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 949 to 1414 | 1 to 466 | 466/466 (100 %) | 1 diff (99.8 %id) | |||
| AA074591 | .a | 949 to 1453 | 1 to 515 | 515/521 (98 %) | 21 diff (96.0 %id) | ||||
| TI_149292268 | .a | 1008 to 1714 | 793 to 88 | AAA | 706/928 (76 %) | 0 diff (100 %id) | |||
| BM974465 | lung | .a | 1030 to 1714 | 701 to 17 | AAA | 685/685 (100 %) | 0 diff (100 %id) | ||
| BX341865 | .a | 1046 to 1948 | 913 to 11 | fully sequenced, | 903/913 (98 %) | 3 diff (99.7 %id) | |||
| BG392355 | embryonal carcinoma, cell line, testis | .a | 1046 to 1736 | 25 to 714 | 690/714 (96 %) | 8 diff (98.9 %id) | |||
| BP314553 | mammary gland | .a | 1080 to 1662 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
| AL524603 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 1110 to 1958 | 849 to 1 | fully sequenced, | 849/849 (100 %) | 1 diff (99.9 %id) | ||
| BQ669521 | epidermoid carcinoma, cell line, salivary gland | .a | 1147 to 1972 | 25 to 850 | 826/953 (86 %) | 22 diff (97.7 %id) | |||
| BP430075 | .a | 1177 to 1533 | 1 to 357 | 357/357 (100 %) | 3 diff (99.2 %id) | ||||
| AA453899 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1178 to 1550 | 12 to 384 | fully sequenced, | 373/384 (97 %) | 6 diff (98.5 %id) | ||
| AA742240 | germinal center B cell | .a | 1189 to 1935 | 777 to 34 | AAA | 744/842 (88 %) | 13 diff (98.5 %id) | ||
| TI_149289792 | .a | 1189 to 1935 | 824 to 87 | AAA | 740/953 (77 %) | 19 diff (98.1 %id) | |||
| TI_154111404 | .a | 1189 to 1976 | 863 to 84 | AAA | 780/931 (83 %) | 16 diff (98.3 %id) | |||
| CB047523 | Kidney | .a | 1202 to 1623 | 7 to 428 | fully sequenced, | 422/428 (98 %) | 7 diff (98.4 %id) | ||
| DB543175 | hippocampus | .a | 1206 to 1935 | 1 to 726 | Submitted on the opposite strand | 726/726 (100 %) | 9 diff (98.8 %id) | ||
| W01170 | liver and spleen | .a | 1237 to 1676 | 1 to 456 | 454/458 (99 %) | 19 diff (95.9 %id) | |||
| BQ008496 | Chondrosarcoma, Left Pubic Bone | .a | 1239 to 1941 | 719 to 19 | AAA | 701/701 (100 %) | 1 diff (99.9 %id) | ||
| BG397419 | B-cells, primary B-cells from tonsils (cell line) | .a | 1250 to 1976 | 1 to 727 | AAA | 727/727 (100 %) | 5 diff (99.4 %id) | ||
| BG398281 | B-cells, primary B-cells from tonsils (cell line) | .a | 1250 to 1978 | 1 to 729 | 729/738 (98 %) | 14 diff (98.2 %id) | |||
| BG759789 | B-cells, primary B-cells from tonsils (cell line) | .a | 1250 to 1884 | 1 to 636 | 636/637 (99 %) | 2 diff (99.7 %id) | |||
| CA448435 | Chondrosarcoma, Left Pubic Bone | .a | 1270 to 1976 | 723 to 19 | AAA | 705/705 (100 %) | 2 diff (99.8 %id) | ||
| BM971135 | lung | .a | 1286 to 1935 | 665 to 19 | AAA | 649/647 (100 %) | 4 diff (99.4 %id) | ||
| N48644 | multiple sclerosis lesions | .a | 1294 to 1519 | 1 to 226 | fully sequenced, | 226/226 (100 %) | 0 diff (100 %id) | ||
| DB515893 | testis | .a | 1297 to 1974 | 19 to 697 | AAA | Submitted on the opposite strand | 679/697 (97 %) | 8 diff (98.9 %id) | |
| AW469502 | pooled | .a | 1298 to 1838 | 541 to 1 | 541/541 (100 %) | 23 diff (95.8 %id) | |||
| AA860492 | parathyroid gland, parathyroid tumor | .a | 1349 to 1978 | 635 to 8 | 628/638 (98 %) | 26 diff (96.0 %id) | |||
| TI_149275129 | .a | 1358 to 1976 | 722 to 95 | AAA | 628/696 (90 %) | 40 diff (94.3 %id) | |||
| BE966163 | leiomyosarcoma, uterus | .a | 1363 to 1977 | 641 to 14 | AAA | 628/837 (75 %) | 26 diff (96.9 %id) | ||
| BF920012 | nervous_tumor | .a | 1364 to 1907 | 548 to 8 | Submitted on the opposite strand | 541/548 (98 %) | 0 diff (100 %id) | ||
| AI823878 | 2 pooled tumors (clear cell type), Kidney | .a | 1366 to 1974 | 610 to 3 | 608/610 (99 %) | 4 diff (99.4 %id) | |||
| AI739313 | colon, colon tumor, RER+ | .a | 1370 to 1946 | 581 to 5 | 577/581 (99 %) | 0 diff (100 %id) | |||
| BU949647 | Pancreas, Purified pancreatic islet | .a | 1371 to 1976 | 623 to 17 | AAA | 607/607 (100 %) | 34 diff (94.4 %id) | ||
| AA768870 | germinal center B cell | .a | 1376 to 1838 | 462 to 1 | 461/517 (89 %) | 47 diff (91.0 %id) | |||
| CK902752 | Pancreas, Purified pancreatic islet | .a | 1388 to 1976 | 615 to 27 | AAA | Submitted on the opposite strand | 589/589 (100 %) | 1 diff (99.9 %id) | |
| AA724383 | parathyroid gland, parathyroid tumor | .a | 1412 to 1978 | 571 to 5 | 567/571 (99 %) | 1 diff (99.9 %id) | |||
| AA725703 | .a | 1412 to 1838 | 427 to 1 | 427/427 (100 %) | 10 diff (97.7 %id) | ||||
| AI041387 | parathyroid gland, parathyroid tumor | .a | 1412 to 1978 | 569 to 5 | 565/572 (98 %) | 24 diff (95.9 %id) | |||
| BJ990606 | hepatoblastoma | .a | 1420 to 1959 | 540 to 1 | 540/540 (100 %) | 0 diff (100 %id) | |||
| FN114777 | breast carcinoma | .a | 1421 to 1495 | 73 to 1 | Submitted on the opposite strand | 73/73 (100 %) | 2 diff (97.3 %id) | ||
| AW382352 | head_neck | .a | 1427 to 1786 | 1 to 358 | 358/358 (100 %) | 3 diff (99.2 %id) | |||
| AW516356 | lymph node, lymphoma, follicular mixed small and largecell | .a | 1433 to 1978 | 553 to 1 | 553/553 (100 %) | 25 diff (95.5 %id) | |||
| FN142869 | breast carcinoma | .a | 1458 to 1547 | 88 to 1 | Submitted on the opposite strand | 88/96 (91 %) | 1 diff (99.0 %id) | ||
| BF919843 | nervous_tumor | .a | 1460 to 1913 | 460 to 8 | Submitted on the opposite strand | 453/460 (98 %) | 0 diff (100 %id) | ||
| AI027069 | parathyroid gland, parathyroid tumor | .a | 1472 to 1978 | 511 to 5 | tiling clone, | 507/511 (99 %) | 0 diff (100 %id) | ||
| AI057240 | liver and spleen | .a | 1472 to 1978 | 512 to 6 | 507/512 (99 %) | 5 diff (99.1 %id) | |||
| AI950277 | pooled germ cell tumors | .a | 1475 to 1609 | 136 to 1 | 136/136 (100 %) | 8 diff (94.2 %id) | |||
| AA453814 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1489 to 1941 | 453 to 1 | fully sequenced, | 453/453 (100 %) | 0 diff (100 %id) | ||
| AA694027 | liver and spleen | .a | 1493 to 1931 | 439 to 1 | 439/439 (100 %) | 3 diff (99.4 %id) | |||
| N34410 | multiple sclerosis lesions | .a | 1509 to 1976 | 471 to 1 | fully sequenced, | 471/471 (100 %) | 4 diff (99.2 %id) | ||
| AA782088 | parathyroid gland, parathyroid tumor | .a | 1518 to 1978 | 465 to 5 | 461/478 (96 %) | 3 diff (99.4 %id) | |||
| AA854687 | parathyroid gland, parathyroid tumor | .a | 1518 to 1978 | 468 to 8 | 461/502 (91 %) | 14 diff (97.3 %id) | |||
| AA713600 | germinal center B cell | .a | 1520 to 1978 | 466 to 8 | 459/466 (98 %) | 4 diff (99.2 %id) | |||
| AA808579 | germinal center B cell | .a | 1523 to 1838 | 316 to 1 | 316/319 (99 %) | 8 diff (97.5 %id) | |||
| AI633609 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1526 to 1978 | 453 to 1 | 453/453 (100 %) | 3 diff (99.4 %id) | |||
| AA731254 | germinal center B cell | .a | 1544 to 1978 | 442 to 8 | 435/442 (98 %) | 0 diff (100 %id) | |||
| FN070507 | breast carcinoma | .a | 1545 to 1635 | 89 to 1 | Submitted on the opposite strand | 89/89 (100 %) | 2 diff (97.8 %id) | ||
| CX868429 | embryonic stem | .a | 1549 to 1976 | 454 to 27 | AAA | 428/428 (100 %) | 2 diff (99.6 %id) | ||
| AA075268 | .a | 1550 to 1973 | 433 to 6 | 428/442 (96 %) | 4 diff (99.1 %id) | ||||
| AI254702 | colon, moderately-differentiated adenocarcinoma | .a | 1553 to 1976 | 450 to 21 | AAA | 430/430 (100 %) | 13 diff (97.0 %id) | ||
| AW662414 | colon, moderately-differentiated adenocarcinoma | .a | 1555 to 1937 | 385 to 3 | 383/385 (99 %) | 0 diff (100 %id) | |||
| AW193015 | adenocarcinoma, Pancreas | .a | 1556 to 1978 | 428 to 7 | 422/428 (98 %) | 5 diff (98.9 %id) | |||
| BU676568 | lung, Primary Lung Epithelial Cells | .a | 1558 to 1976 | 433 to 16 | AAA | 418/418 (100 %) | 1 diff (99.8 %id) | ||
| AA455653 | germinal center B cell | .a | 1560 to 1976 | 431 to 14 | AAA | 418/418 (100 %) | 1 diff (99.8 %id) | ||
| AA783027 | .a | 1570 to 1978 | 417 to 9 | 409/417 (98 %) | 0 diff (100 %id) | ||||
| CB047522 | Kidney | .a | 1593 to 1935 | 390 to 48 | fully sequenced, AAA | 343/343 (100 %) | 6 diff (98.3 %id) | ||
| BU751964 | placenta | .a | 1594 to 1976 | 400 to 18 | AAA | 383/383 (100 %) | 0 diff (100 %id) | ||
| AI433179 | lymph node, lymphoma, follicular mixed small and largecell | .a | 1597 to 1976 | 394 to 15 | AAA | 380/380 (100 %) | 0 diff (100 %id) | ||
| AI675179 | anaplastic oligodendroglioma, brain | .a | 1607 to 1976 | 380 to 11 | AAA | 370/370 (100 %) | 0 diff (100 %id) | ||
| AI554697 | anaplastic oligodendroglioma, brain | .a | 1607 to 1838 | 232 to 1 | 232/232 (100 %) | 1 diff (99.6 %id) | |||
| EC441638 | Prostate | .a | 1620 to 1695 | 99 to 24 | 76/101 (75 %) | 0 diff (100 %id) | |||
| EC483980 | Prostate | .a | 1620 to 1714 | 95 to 1 | 95/97 (97 %) | 3 diff (97.0 %id) | |||
| EC498512 | Prostate | .a | 1620 to 1713 | 96 to 3 | 94/98 (95 %) | 3 diff (97.0 %id) | |||
| EC501495 | Prostate | .a | 1620 to 1714 | 92 to 1 | 92/94 (97 %) | 8 diff (91.5 %id) | |||
| EC528771 | Prostate | .a | 1620 to 1713 | 96 to 3 | 94/98 (95 %) | 3 diff (97.0 %id) | |||
| EC550766 | Prostate | .a | 1620 to 1714 | 107 to 1 | 119/109 (109 %) | 41 diff (62.4 %id) | |||
| EC556598 | Prostate | .a | 1620 to 1713 | 96 to 3 | 94/98 (95 %) | 3 diff (97.0 %id) | |||
| EC559039 | Prostate | .a | 1620 to 1713 | 97 to 4 | 94/99 (94 %) | 3 diff (97.0 %id) | |||
| EC460288 | Prostate | .a | 1622 to 1714 | 114 to 23 | AAA | 92/92 (100 %) | 4 diff (95.7 %id) | ||
| EC465006 | Prostate | .a | 1622 to 1726 | 113 to 12 | 102/113 (90 %) | 4 diff (96.5 %id) | |||
| BQ940185 | eye, normal pigmented retinal epithelium | .a | 1685 to 1976 | 1 to 292 | AAA | 292/292 (100 %) | 0 diff (100 %id) | ||
| AI197903 | anaplastic oligodendroglioma, brain | .a | 1705 to 1976 | 282 to 11 | AAA | 272/272 (100 %) | 0 diff (100 %id) | ||
| FN106297 | breast carcinoma | .a | 1762 to 1824 | 1 to 64 | 64/68 (94 %) | 7 diff (89.8 %id) | |||
| AW366511 | head_neck | .a | 1765 to 1920 | 158 to 2 | 157/158 (99 %) | 0 diff (100 %id) | |||
| AW366528 | head_neck | .a | 1765 to 1924 | 159 to 1 | 159/159 (100 %) | 3 diff (98.2 %id) | |||
| C01402 | .a | 1793 to 1976 | 1 to 184 | 184/184 (100 %) | 0 diff (100 %id) | ||||
| N74083 | liver and spleen | .a | 1799 to 1977 | 179 to 1 | 179/185 (96 %) | 0 diff (100 %id) | |||
| FN126525 | breast carcinoma | .a | 1807 to 1913 | 113 to 1 | Submitted on the opposite strand | 113/116 (97 %) | 5 diff (95.7 %id) | ||
| AI886547 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 1825 to 1976 | 168 to 17 | AAA | 152/152 (100 %) | 1 diff (99.4 %id) | ||
| DA041755 | bladder | .b | 1 to 580 | 2 to 582 | tiling clone, capped | 581/581 (100 %) | 2 diff (99.7 %id) | ||
| AK226065 | brain | .b | 453 to 5024 | 1 to 4576 | exact | tiling clone, AAA | 4576/4576 (100 %) | 2 diff (100.0 %id) | |
| DC334932 | hippocampus | .b | 1309 to 1859 | 1 to 551 | 551/552 (99 %) | 2 diff (99.7 %id) | |||
| DC325487 | brain | .b | 1331 to 1898 | 1 to 570 | 570/570 (100 %) | 3 diff (99.5 %id) | |||
| CN315002 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 1734 to 2307 | 1 to 574 | tiling clone, | 574/574 (100 %) | 2 diff (99.7 %id) | ||
| FN131472 | breast carcinoma | .b | 2382 to 2487 | 104 to 1 | Submitted on the opposite strand | 104/104 (100 %) | 2 diff (98.1 %id) | ||
| AA004493 | liver and spleen | .b | 2524 to 2878 | 1 to 358 | 358/358 (100 %) | 5 diff (98.7 %id) | |||
| AL703483 | human skeletal muscle | .b | 2583 to 3186 | 1 to 604 | 604/604 (100 %) | 3 diff (99.6 %id) | |||
| BX471742 | .b | 2607 to 2965 | 1 to 359 | 359/359 (100 %) | 0 diff (100 %id) | ||||
| DA519446 | brain | .b | 2772 to 3313 | 2 to 543 | capped | 542/542 (100 %) | 1 diff (99.9 %id) | ||
| FN086127 | breast carcinoma | .b | 3317 to 3396 | 81 to 1 | Submitted on the opposite strand | 81/95 (85 %) | 4 diff (95.8 %id) | ||
| CN308286 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 3608 to 4307 | 1 to 698 | 698/698 (100 %) | 3 diff (99.6 %id) | |||
| N50772 | multiple sclerosis lesions | .b | 3733 to 4097 | 1 to 369 | 369/380 (97 %) | 9 diff (97.7 %id) | |||
| AA004597 | liver and spleen | .b | 4648 to 4982 | 336 to 1 | 336/337 (99 %) | 1 diff (99.8 %id) | |||
| N50688 | multiple sclerosis lesions | .b | 4659 to 5009 | 365 to 1 | 365/383 (95 %) | 14 diff (96.4 %id) | |||
| DR761141 | embryonic stem | .c | 1 to 830 | 1 to 830 | tiling clone, | 830/830 (100 %) | 0 diff (100 %id) | ||
| BF352931 | head_neck | .c | 634 to 1181 | 1 to 548 | tiling clone, | 548/548 (100 %) | 3 diff (99.5 %id) | ||
| BQ352173 | head_neck | .c | 634 to 1181 | 1 to 548 | 548/548 (100 %) | 3 diff (99.5 %id) | |||
| CR743119 | .c | 779 to 1164 | 386 to 1 | Submitted on the opposite strand | 386/386 (100 %) | 0 diff (100 %id) | |||
| CN266727 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .c | 900 to 1349 | 1 to 449 | tiling clone, | 449/449 (100 %) | 3 diff (99.4 %id) | ||
| BG281183 | melanotic melanoma, skin | .c | 1330 to 2023 | 1 to 694 | tiling clone, | 694/694 (100 %) | 5 diff (99.3 %id) | ||
| D63183 | .c | 1557 to 1885 | 1 to 328 | tiling clone, | 328/328 (100 %) | 2 diff (99.4 %id) | |||
| CX865515 | embryonic stem | .c | 1782 to 1887 | 1 to 106 | 106/106 (100 %) | 0 diff (100 %id) | |||
| AK302452 | testis | .d | 1 to 940 | 1 to 940 | exact | tiling clone, | 940/940 (100 %) | 0 diff (100 %id) | |
| DC341477 | thalamus | .d | 364 to 951 | 1 to 588 | tiling clone, | 588/588 (100 %) | 2 diff (99.7 %id) | ||
| BM926431 | brain | .e | 1 to 843 | 15 to 862 | exact | tiling clone, | 848/1116 (75 %) | 53 diff (95.3 %id) | |
| CX753870 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .e | 10 to 716 | 1 to 698 | exact | 698/825 (84 %) | 21 diff (97.5 %id) | ||
| BX380341 | Placenta Cot 25-normalized | .e | 29 to 827 | 1 to 799 | V48X S97X | tiling clone, | 799/799 (100 %) | 0 diff (100 %id) | |
| BQ073192 | leukocyte | .e | 35 to 726 | 1 to 702 | N62H E98Q E135Q | available from MGC, | 702/1206 (58 %) | 38 diff (96.9 %id) | |
| BX380340 | Placenta Cot 25-normalized | .e | 849 to 1660 | 811 to 1 | tiling clone, | 811/811 (100 %) | 2 diff (99.8 %id) | ||
| AI480064 | anaplastic oligodendroglioma, brain | .f | 1 to 582 | 583 to 1 | S2Q A3P K9R P26Q A27L ... | tiling clone, | 583/583 (100 %) | 9 diff (98.5 %id) | |
| AA909660 | pooled | .g | 1 to 572 | 573 to 2 | exact | tiling clone, | 572/573 (99 %) | 0 diff (100 %id) | |
| DB012020 | esophageal, tumor tissue | .h | 1 to 559 | 2 to 560 | exact | tiling clone, capped | 559/559 (100 %) | 1 diff (99.9 %id) | |
| DA694856 | .i | 1 to 557 | 2 to 558 | exact | tiling clone, capped | 557/557 (100 %) | 1 diff (99.9 %id) | ||
| DA726152 | .i | 3 to 563 | 2 to 562 | exact | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
| DB061489 | testis | .i | 3 to 559 | 2 to 559 | exact | capped | 558/558 (100 %) | 1 diff (99.9 %id) | |
| DA522575 | brain | .i | 5 to 565 | 2 to 562 | exact | capped | 561/561 (100 %) | 0 diff (100 %id) | |
| DB227669 | trachea | .i | 50 to 615 | 2 to 567 | exact | capped | 566/566 (100 %) | 1 diff (99.9 %id) | |
| BC108738 | Skin, melanotic melanoma. | .i | 62 to 2549 | 1 to 2488 | exact | AAA | 2488/2488 (100 %) | 2 diff (100.0 %id) | |
| BQ424016 | melanotic melanoma, skin | .i | 65 to 955 | 1 to 905 | N86X Y87L P88S | 905/905 (100 %) | 30 diff (96.7 %id) | ||
| DA756041 | .i | 94 to 663 | 2 to 571 | exact | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| CF593935 | Human Placenta, placenta | .i | 98 to 864 | 29 to 802 | exact | 774/813 (95 %) | 14 diff (98.3 %id) | ||
| DA708033 | .i | 102 to 654 | 2 to 554 | exact | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| BU595832 | mixed (pool of 40 RNAs) | .i | 127 to 887 | 1 to 769 | exact | 769/824 (93 %) | 19 diff (97.7 %id) | ||
| DR002568 | fetal brain | .i | 136 to 617 | 7 to 489 | exact | 483/489 (98 %) | 4 diff (99.2 %id) | ||
| DA237417 | brain | .i | 139 to 674 | 2 to 537 | exact | capped | 536/536 (100 %) | 0 diff (100 %id) | |
| DA998414 | .i | 150 to 711 | 2 to 563 | exact | capped | 562/563 (99 %) | 1 diff (99.9 %id) | ||
| BP354673 | .i | 152 to 733 | 1 to 581 | V6L | 581/581 (100 %) | 6 diff (99.0 %id) | |||
| DA196140 | amygdala | .i | 153 to 713 | 2 to 562 | exact | capped | 561/561 (100 %) | 0 diff (100 %id) | |
| DA233504 | brain | .i | 153 to 708 | 2 to 557 | exact | capped | 556/556 (100 %) | 1 diff (99.9 %id) | |
| DA279320 | corpus callosum | .i | 153 to 742 | 2 to 591 | exact | capped | 590/590 (100 %) | 0 diff (100 %id) | |
| DA799136 | brain | .i | 153 to 684 | 2 to 534 | exact | capped | 533/533 (100 %) | 1 diff (99.9 %id) | |
| DA803823 | brain | .i | 153 to 693 | 2 to 542 | exact | capped | 541/541 (100 %) | 0 diff (100 %id) | |
| BP320471 | placenta | .i | 153 to 735 | 1 to 583 | exact | 583/583 (100 %) | 0 diff (100 %id) | ||
| BP320501 | placenta | .i | 153 to 739 | 1 to 588 | exact | 588/588 (100 %) | 7 diff (98.9 %id) | ||
| DB068041 | testis | .i | 153 to 686 | 2 to 535 | exact | capped | 534/534 (100 %) | 0 diff (100 %id) | |
| DB147101 | thymus | .i | 153 to 728 | 2 to 577 | exact | capped | 576/576 (100 %) | 1 diff (99.9 %id) | |
| DB285184 | uterus | .i | 153 to 700 | 2 to 549 | exact | capped | 548/548 (100 %) | 0 diff (100 %id) | |
| BP201640 | amygdala | .i | 154 to 735 | 1 to 582 | exact | 582/582 (100 %) | 0 diff (100 %id) | ||
| DA321573 | hippocampus | .i | 155 to 682 | 2 to 529 | exact | capped | 528/528 (100 %) | 0 diff (100 %id) | |
| DA951716 | Spleen | .i | 155 to 712 | 2 to 559 | K53R | capped | 558/558 (100 %) | 3 diff (99.5 %id) | |
| TI_57183065 | .i | 160 to 1001 | 28 to 873 | exact | 846/874 (96 %) | 19 diff (97.9 %id) | |||
| BI771522 | pooled lung and spleen | .i | 161 to 1001 | 1 to 845 | exact | 845/846 (99 %) | 14 diff (98.4 %id) | ||
| DA460719 | tongue, tumor tissue | .i | 162 to 708 | 2 to 548 | exact | capped | 547/547 (100 %) | 0 diff (100 %id) | |
| BI914241 | brain | .i | 163 to 1001 | 1 to 842 | I47M V48L G49D L50W A51Q ... | 842/844 (99 %) | 18 diff (97.9 %id) | ||
| TI_57241688 | .i | 163 to 1001 | 32 to 873 | I47M V48L G49D L50W A51Q ... | 842/875 (96 %) | 22 diff (97.5 %id) | |||
| DB456761 | testis | .i | 164 to 646 | 1 to 483 | exact | 483/494 (97 %) | 2 diff (99.6 %id) | ||
| BC065281 | Eye, retinoblastoma | .i | 165 to 2549 | 1 to 2385 | exact | tiling clone, available from MGC, AAA | 2385/2385 (100 %) | 0 diff (100 %id) | |
| BU161964 | eye, retinoblastoma | .i | 167 to 657 | 1 to 506 | exact | available from MGC, | 506/822 (61 %) | 23 diff (97.3 %id) | |
| BI545350 | brain, hippocampus | .i | 169 to 933 | 1 to 767 | Y18C Q75R | 767/767 (100 %) | 10 diff (98.7 %id) | ||
| DA233901 | brain | .i | 171 to 754 | 2 to 585 | exact | capped | 584/584 (100 %) | 0 diff (100 %id) | |
| TI_44165427 | .i | 173 to 933 | 131 to 893 | Y18C Q75R | 763/893 (85 %) | 11 diff (98.8 %id) | |||
| DB064308 | testis | .i | 189 to 736 | 2 to 550 | G78X P79S W80L T81D W82L ... | capped | 549/549 (100 %) | 1 diff (99.9 %id) | |
| DB064349 | testis | .i | 189 to 725 | 2 to 538 | exact | capped | 537/537 (100 %) | 0 diff (100 %id) | |
| BU428885 | lymph | .i | 192 to 614 | 1 to 423 | exact | 423/423 (100 %) | 4 diff (99.1 %id) | ||
| TI_154149726 | .i | 197 to 672 | 78 to 553 | exact | 476/476 (100 %) | 2 diff (99.6 %id) | |||
| TI_154149728 | .i | 197 to 671 | 95 to 569 | V26D A37P E46* | 475/476 (99 %) | 23 diff (95.2 %id) | |||
| DA159277 | amygdala | .i | 211 to 765 | 2 to 556 | exact | capped | 555/555 (100 %) | 0 diff (100 %id) | |
| CA406459 | adipose | .i | 211 to 686 | 1 to 477 | exact | 477/477 (100 %) | 3 diff (99.4 %id) | ||
| DA485876 | brain | .i | 211 to 793 | 2 to 584 | exact | capped | 583/583 (100 %) | 1 diff (99.9 %id) | |
| DB201158 | trachea | .i | 211 to 802 | 2 to 593 | exact | capped | 592/592 (100 %) | 0 diff (100 %id) | |
| CR746848 | brain | .i | 221 to 735 | 1 to 515 | exact | 515/515 (100 %) | 0 diff (100 %id) | ||
| BM926833 | brain | .i | 222 to 1110 | 1 to 900 | exact | 900/1032 (87 %) | 16 diff (98.5 %id) | ||
| AL138383 | melanoma (MeWo cell line) | .i | 236 to 989 | 1 to 754 | exact | 754/754 (100 %) | 0 diff (100 %id) | ||
| EL735126 | mixed | .i | 239 to 504 | 1 to 266 | 266/439 (60 %) | 0 diff (100 %id) | |||
| BM015914 | breast, mammary adenocarcinoma, cell line | .i | 268 to 1002 | 1 to 731 | 733/741 (98 %) | 14 diff (98.2 %id) | |||
| TI_59394282 | .i | 268 to 1002 | 48 to 778 | 733/741 (98 %) | 14 diff (98.2 %id) | ||||
| DA218314 | brain | .i | 340 to 878 | 2 to 540 | capped | 539/539 (100 %) | 0 diff (100 %id) | ||
| BG898757 | cartilage | .i | 411 to 955 | 86 to 630 | 545/562 (96 %) | 8 diff (98.6 %id) | |||
| F13149 | brain, total brain | .i | 459 to 774 | 1 to 316 | 316/316 (100 %) | 1 diff (99.7 %id) | |||
| H06893 | whole brain | .i | 460 to 864 | 1 to 418 | 418/420 (99 %) | 19 diff (95.5 %id) | |||
| H09413 | whole brain | .i | 461 to 864 | 1 to 404 | 404/405 (99 %) | 8 diff (98.1 %id) | |||
| AW372167 | breast | .i | 462 to 1033 | 10 to 575 | 566/614 (92 %) | 19 diff (97.0 %id) | |||
| T75346 | whole brain | .i | 492 to 882 | 1 to 395 | 395/396 (99 %) | 14 diff (96.5 %id) | |||
| CN267083 | embryonic stem cells, cell lines H1, H7, andH9 | .i | 754 to 984 | 1 to 231 | 231/231 (100 %) | 0 diff (100 %id) | |||
| CX781591 | human embryonic stem cells | .i | 828 to 1646 | 1 to 819 | 819/819 (100 %) | 0 diff (100 %id) | |||
| AA332356 | Embryo, 8 weeks | .i | 844 to 1087 | 1 to 246 | 246/246 (100 %) | 6 diff (97.6 %id) | |||
| AI091299 | pooled | .i | 966 to 1318 | 559 to 207 | AAA | 353/549 (64 %) | 0 diff (100 %id) | ||
| BF037352 | adenocarcinoma, ovary | .i | 973 to 1631 | 1 to 653 | 653/656 (99 %) | 7 diff (99.0 %id) | |||
| BC026226 | Prostate, adenocarcinoma. | .i | 1045 to 4800 | 1 to 3757 | tiling clone, available from MGC, AAA | 3757/3757 (100 %) | 1 diff (100.0 %id) | ||
| BG180122 | adenocarcinoma, cell line, Prostate | .i | 1046 to 1670 | 1 to 627 | available from MGC, | 627/832 (75 %) | 27 diff (96.8 %id) | ||
| CF136505 | lymph | .i | 1106 to 1687 | 8 to 589 | 582/589 (98 %) | 6 diff (99.0 %id) | |||
| TI_154165586 | .i | 1106 to 1873 | 80 to 857 | 778/782 (99 %) | 20 diff (97.5 %id) | ||||
| CR601479 | Placenta Cot 25-normalized | .i | 1119 to 2537 | 1 to 1419 | 1419/1419 (100 %) | 0 diff (100 %id) | |||
| BX359012 | Placenta Cot 25-normalized | .i | 1120 to 1874 | 1 to 754 | 754/754 (100 %) | 5 diff (99.4 %id) | |||
| BX365123 | Placenta Cot 25-normalized | .i | 1120 to 2022 | 1 to 894 | 894/950 (94 %) | 15 diff (98.5 %id) | |||
| H09354 | whole brain | .i | 1334 to 1797 | 475 to 2 | 474/477 (99 %) | 0 diff (100 %id) | |||
| CD513807 | brain, Pituitary | .i | 1345 to 2151 | 55 to 871 | 817/969 (84 %) | 27 diff (97.3 %id) | |||
| BQ954088 | leiomyosarcoma, uterus | .i | 1351 to 2162 | 1 to 817 | 817/880 (92 %) | 18 diff (98.0 %id) | |||
| BX365122 | Placenta Cot 25-normalized | .i | 1400 to 2510 | 1103 to 1 | 1103/1131 (97 %) | 32 diff (97.2 %id) | |||
| R39268 | whole brain | .i | 1440 to 1797 | 355 to 2 | 354/407 (86 %) | 0 diff (100 %id) | |||
| AA417773 | germinal center B cell | .i | 1459 to 1691 | 1 to 232 | 232/232 (100 %) | 1 diff (99.6 %id) | |||
| BX117995 | germinal center B cell | .i | 1460 to 2184 | 1 to 725 | 725/725 (100 %) | 0 diff (100 %id) | |||
| EB388502 | eye, optic nerve | .i | 1508 to 2361 | 1 to 854 | 854/854 (100 %) | 0 diff (100 %id) | |||
| F10752 | brain, total brain | .i | 1513 to 1790 | 277 to 1 | 277/277 (100 %) | 2 diff (99.3 %id) | |||
| BX448046 | fetal liver, Liver | .i | 1540 to 2499 | 948 to 1 | 948/954 (99 %) | 32 diff (96.7 %id) | |||
| BM765434 | stomach | .i | 1592 to 2246 | 1 to 655 | 655/655 (100 %) | 0 diff (100 %id) | |||
| H06852 | whole brain | .i | 1641 to 1797 | 158 to 2 | 157/159 (98 %) | 0 diff (100 %id) | |||
| BU690054 | Human Lung Epithelial cells, lung | .i | 1802 to 2533 | 741 to 19 | AAA | 723/726 (99 %) | 15 diff (98.0 %id) | ||
| CX781528 | human embryonic stem cells | .i | 1838 to 2544 | 731 to 25 | AAA | 707/707 (100 %) | 0 diff (100 %id) | ||
| BM993885 | Bone, Subchondral Bone | .i | 1891 to 2544 | 672 to 19 | AAA | 654/654 (100 %) | 2 diff (99.7 %id) | ||
| CN479420 | Bone, Subchondral Bone | .i | 1891 to 2544 | 672 to 19 | AAA | 654/654 (100 %) | 2 diff (99.7 %id) | ||
| AI820056 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .i | 1927 to 2536 | 615 to 6 | 610/615 (99 %) | 0 diff (100 %id) | |||
| AI422277 | brain, glioblastoma (pooled) | .i | 1995 to 2545 | 550 to 1 | 550/550 (100 %) | 2 diff (99.7 %id) | |||
| AI417376 | anaplastic oligodendroglioma, brain | .i | 2012 to 2541 | 530 to 1 | 530/530 (100 %) | 0 diff (100 %id) | |||
| DA031289 | .i | 2024 to 2598 | 2 to 577 | capped | 576/576 (100 %) | 2 diff (99.7 %id) | |||
| AI361024 | brain, glioblastoma (pooled) | .i | 2027 to 2545 | 518 to 1 | 518/518 (100 %) | 1 diff (99.9 %id) | |||
| AA356341 | .i | 2047 to 2312 | 1 to 266 | 266/266 (100 %) | 1 diff (99.7 %id) | ||||
| AW958607 | .i | 2048 to 2621 | 1 to 572 | 572/574 (99 %) | 12 diff (98.0 %id) | ||||
| AI918104 | anaplastic oligodendroglioma, brain | .i | 2069 to 2541 | 473 to 1 | 473/473 (100 %) | 0 diff (100 %id) | |||
| AL039861. matches multiple genes | testis | .i | 2073 to 2550 | 1 to 478 | also hits gene FAM84B | 478/483 (98 %) | 1 diff (99.8 %id) | ||
| AI073525 | pooled | .i | 2086 to 2538 | 457 to 5 | 453/457 (99 %) | 0 diff (100 %id) | |||
| AI655030 | pooled germ cell tumors | .i | 2095 to 2529 | 449 to 15 | 435/449 (96 %) | 0 diff (100 %id) | |||
| AW468483 | myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood | .i | 2100 to 2539 | 440 to 1 | 440/440 (100 %) | 0 diff (100 %id) | |||
| AV757332 | bone marrow | .i | 2115 to 2539 | 99 to 523 | AAA | 425/434 (97 %) | 6 diff (98.7 %id) | ||
| AI123753 | pooled | .i | 2117 to 2545 | 434 to 6 | 429/434 (98 %) | 0 diff (100 %id) | |||
| AA417742 | germinal center B cell | .i | 2136 to 2539 | 404 to 1 | 404/404 (100 %) | 0 diff (100 %id) | |||
| AA862117 | squamous cell carcinoma from base of tongue, tongue | .i | 2152 to 2548 | 401 to 5 | 397/401 (99 %) | 0 diff (100 %id) | |||
| AI619815 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .i | 2202 to 2533 | 341 to 12 | AAA | 330/330 (100 %) | 1 diff (99.7 %id) | ||
| DA617870 | .i | 2303 to 2872 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | |||
| AI423665 | brain, glioblastoma (pooled) | .i | 2321 to 2418 | 98 to 1 | 98/98 (100 %) | 0 diff (100 %id) | |||
| BQ023510 | placenta | .i | 2340 to 2554 | 232 to 18 | AAA | 215/215 (100 %) | 0 diff (100 %id) | ||
| AW408674 | lymph | .i | 2457 to 2788 | 1 to 332 | 332/332 (100 %) | 5 diff (98.5 %id) | |||
| TI_154148590 | .i | 2463 to 3025 | 79 to 633 | 555/591 (93 %) | 15 diff (97.5 %id) | ||||
| BU189238 | melanotic melanoma, skin | .i | 2645 to 3252 | 1 to 614 | 614/919 (66 %) | 25 diff (97.3 %id) | |||
| BC015696 | Primary B-Cells from Tonsils | .i | 2650 to 3764 | 1 to 1115 | tiling clone, available from MGC, AAA | 1115/1115 (100 %) | 0 diff (100 %id) | ||
| BG258041 | embryonal carcinoma, cell line, testis | .i | 2671 to 3216 | 1 to 545 | 545/545 (100 %) | 5 diff (99.1 %id) | |||
| DA153576 | amygdala | .i | 2710 to 3295 | 2 to 587 | capped | 586/586 (100 %) | 1 diff (99.9 %id) | ||
| BQ353979 | head_neck | .i | 2787 to 3176 | 1 to 390 | 390/390 (100 %) | 2 diff (99.5 %id) | |||
| BG999077 | head_neck | .i | 2791 to 3181 | 20 to 410 | 391/410 (95 %) | 6 diff (98.6 %id) | |||
| AI880192 | astrocytoma, brain | .i | 2927 to 3143 | 217 to 1 | 217/217 (100 %) | 0 diff (100 %id) | |||
| BG403208 | bladder, transitional cell papilloma, cell line | .i | 2995 to 3498 | 1 to 504 | 504/504 (100 %) | 6 diff (98.9 %id) | |||
| BG402944 | bladder, transitional cell papilloma, cell line | .i | 2995 to 3606 | 1 to 612 | 612/617 (99 %) | 19 diff (97.0 %id) | |||
| BQ432755 | bone marrow, from acute myelogenous leukemia | .i | 3002 to 3768 | 1 to 774 | 774/775 (99 %) | 10 diff (98.8 %id) | |||
| BG754460 | B-cells, primary B-cells from tonsils (cell line) | .i | 3161 to 3455 | 620 to 909 | available from MGC, | 290/1080 (26 %) | 6 diff (99.5 %id) | ||
| AA405549 | .i | 3408 to 3765 | 1 to 357 | 357/357 (100 %) | 3 diff (99.2 %id) | ||||
| AW838204 | leiomios | .i | 3506 to 4021 | 533 to 15 | 519/533 (97 %) | 0 diff (100 %id) | |||
| BI333441 | cervical carcinoma cell line, cervix | .i | 3668 to 4312 | 13 to 651 | 639/651 (98 %) | 6 diff (99.1 %id) | |||
| AI367325 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .i | 3702 to 4045 | 24 to 367 | AAA | Submitted on the opposite strand | 344/367 (93 %) | 6 diff (98.4 %id) | |
| AA504588 | germinal center B cell | .i | 3722 to 4248 | 1 to 524 | 524/529 (99 %) | 5 diff (99.1 %id) | |||
| EL953386 | eyeball | .i | 3738 to 4205 | 1 to 469 | 469/469 (100 %) | 5 diff (99.0 %id) | |||
| H25950 | breast | .i | 3818 to 4224 | 1 to 422 | 422/438 (96 %) | 17 diff (96.2 %id) | |||
| AA236105 | germinal center B cell | .i | 3825 to 4196 | 1 to 372 | 372/372 (100 %) | 2 diff (99.5 %id) | |||
| AW966895 | .i | 3826 to 4342 | 35 to 551 | 517/551 (93 %) | 6 diff (99.0 %id) | ||||
| BQ341201 | nervous_normal | .i | 3914 to 4171 | 273 to 11 | 263/273 (96 %) | 0 diff (100 %id) | |||
| TI_154094398 | .i | 4010 to 4796 | 886 to 73 | AAA | 814/1274 (63 %) | 65 diff (94.9 %id) | |||
| FN170838 | breast carcinoma | .i | 4049 to 4134 | 1 to 88 | 88/89 (98 %) | 6 diff (93.3 %id) | |||
| AW966900 | .i | 4050 to 4799 | 749 to 1 | Submitted on the opposite strand | 749/751 (99 %) | 10 diff (98.7 %id) | |||
| BU632441 | cell lines, Chondrosarcoma | .i | 4062 to 4796 | 753 to 19 | AAA | 735/735 (100 %) | 0 diff (100 %id) | ||
| CB594800 | Blood, promyelocytic leukemia | .i | 4075 to 4524 | 1 to 450 | 450/453 (99 %) | 3 diff (99.4 %id) | |||
| AL138384 | melanoma (MeWo cell line) | .i | 4088 to 4818 | 748 to 18 | AAA | 731/731 (100 %) | 0 diff (100 %id) | ||
| AW967523 | .i | 4132 to 4799 | 668 to 1 | Submitted on the opposite strand | 668/668 (100 %) | 12 diff (98.3 %id) | |||
| AW503902 | lymph | .i | 4141 to 4613 | 8 to 480 | 473/480 (98 %) | 6 diff (98.8 %id) | |||
| TI_154159924 | .i | 4141 to 4781 | 91 to 718 | 628/646 (97 %) | 37 diff (94.3 %id) | ||||
| BQ002432 | Chondrosarcoma, Left Pelvis | .i | 4187 to 4800 | 632 to 19 | AAA | 614/614 (100 %) | 1 diff (99.9 %id) | ||
| CA436980 | Bone, Subchondral Bone | .i | 4187 to 4796 | 628 to 19 | AAA | 610/610 (100 %) | 0 diff (100 %id) | ||
| TI_154171399 | .i | 4211 to 4801 | 686 to 88 | Submitted on the opposite strand | 599/1063 (56 %) | 0 diff (100 %id) | |||
| AV735618 | cord Blood | .i | 4216 to 4793 | 41 to 610 | 570/613 (92 %) | 15 diff (97.6 %id) | |||
| BX115421 | placenta | .i | 4217 to 4796 | 1 to 580 | AAA | 580/580 (100 %) | 1 diff (99.9 %id) | ||
| R26008 | placenta | .i | 4217 to 4585 | 1 to 376 | 376/411 (91 %) | 13 diff (96.9 %id) | |||
| R64412 | placenta | .i | 4217 to 4606 | 1 to 396 | fully sequenced, | 396/396 (100 %) | 10 diff (97.5 %id) | ||
| R78587 | placenta | .i | 4244 to 4518 | 1 to 279 | fully sequenced, | Submitted on the opposite strand | 279/279 (100 %) | 0 diff (100 %id) | |
| DB301813 | amygdala | .i | 4259 to 4800 | 542 to 1 | 542/542 (100 %) | 0 diff (100 %id) | |||
| BE644664 | pooled | .i | 4271 to 4796 | 538 to 13 | AAA | 526/526 (100 %) | 1 diff (99.9 %id) | ||
| BM727282 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .i | 4300 to 4800 | 1 to 501 | AAA | 501/501 (100 %) | 0 diff (100 %id) | ||
| BQ185962 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .i | 4300 to 4800 | 1 to 501 | AAA | 501/501 (100 %) | 0 diff (100 %id) | ||
| DB522191 | testis | .i | 4316 to 4799 | 1 to 484 | Submitted on the opposite strand | 484/484 (100 %) | 0 diff (100 %id) | ||
| BF055430 | pooled | .i | 4327 to 4800 | 484 to 11 | AAA | 474/474 (100 %) | 1 diff (99.8 %id) | ||
| BF749347 | breast_normal | .i | 4331 to 4777 | 450 to 5 | Submitted on the opposite strand | 446/450 (99 %) | 0 diff (100 %id) | ||
| AI359774 | brain, glioblastoma (pooled) | .i | 4331 to 4800 | 469 to 1 | 469/469 (100 %) | 1 diff (99.8 %id) | |||
| AI222758 | adenocarcinoma, colon | .i | 4338 to 4801 | 468 to 5 | 464/468 (99 %) | 0 diff (100 %id) | |||
| AI499688 | anaplastic oligodendroglioma, brain | .i | 4340 to 4800 | 460 to 1 | 460/460 (100 %) | 3 diff (99.4 %id) | |||
| AI285942 | pooled | .i | 4343 to 4801 | 464 to 7 | 458/464 (98 %) | 0 diff (100 %id) | |||
| AW072370 | pooled | .i | 4363 to 4801 | 441 to 3 | 439/441 (99 %) | 0 diff (100 %id) | |||
| AI042411 | senescent fibroblast | .i | 4367 to 4796 | 443 to 14 | AAA | 430/430 (100 %) | 0 diff (100 %id) | ||
| AA928406 | adenocarcinoma, colon | .i | 4369 to 4754 | 386 to 1 | 386/386 (100 %) | 1 diff (99.8 %id) | |||
| AI817207 | pooled | .i | 4369 to 4800 | 442 to 11 | AAA | 432/432 (100 %) | 6 diff (98.7 %id) | ||
| BE002539 | breast_normal | .i | 4376 to 4773 | 401 to 5 | Submitted on the opposite strand | 397/401 (99 %) | 0 diff (100 %id) | ||
| CF140807 | CNCAP(3)T-225 cell line, Prostate | .i | 4382 to 4801 | 435 to 16 | Submitted on the opposite strand | 420/435 (96 %) | 0 diff (100 %id) | ||
| DB537660 | hippocampus | .i | 4383 to 4800 | 1 to 415 | Submitted on the opposite strand | 415/415 (100 %) | 37 diff (91.1 %id) | ||
| AI130765 | heart | .i | 4393 to 4800 | 408 to 1 | 408/408 (100 %) | 0 diff (100 %id) | |||
| AW016387 | .i | 4404 to 4800 | 414 to 18 | AAA | 397/397 (100 %) | 0 diff (100 %id) | |||
| AI073537 | pooled | .i | 4419 to 4800 | 391 to 11 | AAA | 381/381 (100 %) | 4 diff (99.0 %id) | ||
| AI082279 | pooled germ cell tumors | .i | 4421 to 4797 | 378 to 2 | 377/378 (99 %) | 0 diff (100 %id) | |||
| AW768816 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .i | 4427 to 4801 | 388 to 8 | 381/388 (98 %) | 0 diff (100 %id) | |||
| R78588 | placenta | .i | 4488 to 4791 | 313 to 1 | fully sequenced, | Submitted on the opposite strand | 313/313 (100 %) | 0 diff (100 %id) | |
| AA632365 | breast | .i | 4499 to 4801 | 306 to 4 | 303/306 (99 %) | 0 diff (100 %id) | |||
| AA235822 | germinal center B cell | .i | 4554 to 4801 | 254 to 8 | 247/254 (97 %) | 0 diff (100 %id) | |||
| AW593165 | pooled | .i | 4565 to 4801 | 239 to 3 | 237/239 (99 %) | 0 diff (100 %id) | |||
| AI023969 | parathyroid gland, parathyroid tumor | .i | 4568 to 4796 | 241 to 13 | AAA | 229/229 (100 %) | 0 diff (100 %id) | ||
| R63806 | placenta | .i | 4576 to 4801 | 230 to 1 | fully sequenced, | 230/230 (100 %) | 3 diff (98.7 %id) | ||
| Z20444 | .i | 4587 to 4790 | 207 to 1 | 207/209 (99 %) | 7 diff (96.7 %id) | ||||
| AA992731 | .i | 4593 to 4820 | 231 to 4 | tiling clone, | 228/231 (98 %) | 0 diff (100 %id) | |||
| AA910817 | carcinoid, lung | .i | 4594 to 4797 | 215 to 12 | 204/215 (94 %) | 0 diff (100 %id) | |||
| FN122599 | breast carcinoma | .i | 4642 to 4724 | 1 to 83 | 83/96 (86 %) | 1 diff (99.0 %id) | |||
| DA333679 | hippocampus | .j | 1 to 569 | 2 to 571 | G24W V25C V26G A27C N28K ... | tiling clone, capped | 570/570 (100 %) | 2 diff (99.7 %id) | |
| AA315659 | colon | .k | 1 to 466 | 1 to 467 | exact | tiling clone, | 467/467 (100 %) | 3 diff (99.4 %id) | |
| AW954859 | .k | 2 to 570 | 1 to 569 | exact | tiling clone, | 569/611 (93 %) | 6 diff (99.1 %id) | ||
| BQ940574 | sciatic nerve | .l | 1 to 854 | 1 to 860 | H42P V44G R45E G46R N47K ... | tiling clone, | 860/860 (100 %) | 10 diff (98.9 %id) | |
| N53244 | multiple sclerosis lesions | .m-u | 1 to 370 | 32 to 408 | R2X Q9L R10G F11V L12F ... | tiling clone, fully sequenced, | 377/408 (92 %) | 6 diff (98.6 %id) | |
| N48046 | multiple sclerosis lesions | .m-u | 340 to 606 | 269 to 1 | tiling clone, fully sequenced, | 269/269 (100 %) | 1 diff (99.7 %id) | ||
| BE174300 | head_neck | .m-u | 429 to 825 | 416 to 21 | tiling clone, | Submitted on the opposite strand | 396/429 (92 %) | 0 diff (100 %id) | |
| AV703799 | adrenal gland | Gene HSPA14, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AK000880 | whole embryo, mainly head | Gene HSPA14, variant not shown | available from FLJ, | Suspected internal deletion, this clone was ignored | |||||
| DB313874 | tongue, tumor tissue | Gene HSPA14, variant not shown | This clone was ignored | ||||||
| DA444150 | tongue, tumor tissue | Gene HSPA14, variant not shown | capped | This clone was ignored | |||||
| EC501000 | Prostate | Gene HSPA14, variant not shown | This clone was ignored | ||||||
| AU143970 | whole embryo, mainly head | Gene HSPA14, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AU117039 | whole embryo, mainly head | Gene HSPA14, variant not shown | capped | Suspected internal deletion, this clone was ignored | |||||
| AI138387 | Gene HSPA14, variant not shown | Suspected internal deletion, this clone was ignored | |||||||
| AI499830 | anaplastic oligodendroglioma, brain | Gene HSPA14, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BC038845 | Blood, adult leukocytes | Gene HSPA14, variant not shown | available from MGC, AAA | Suspected internal deletion, this clone was ignored | |||||
| CX865471 | embryonic stem | Gene HSPA14, variant not shown | Submitted on the opposite strand, submitted on the opposite strand | ||||||
| DA709167 | Gene HSPA14, variant not shown | capped | Suspected internal deletion, this clone was ignored | ||||||
| DB144806 | thymus | Gene HSPA14, variant not shown | capped | This clone was ignored | |||||
| DB345654 | thymus | Gene HSPA14, variant not shown | This clone was ignored |